Publications by authors named "R B Toma"
A prolonged tuberculosis outbreak, linked by whole-genome sequencing, occurred in a Pasifika extended family over 10 years (2013-2022) in Sydney, Australia. Despite Australia's low tuberculosis incidence, social and cultural complexities, and coronavirus disease 2019 (COVID-19) disruptions exacerbated transmission. Control required culturally sensitive, family-centered care and robust health system engagement.
View Article and Find Full Text PDFAutism rates have been reported to be increasing rapidly in industrialized societies. The pathology most often combines neurological symptoms associated with language and social impairments with gastrointestinal symptoms. This study aimed to measure differences in oral metatranscriptome and mitochondrial health between ASD children and neurotypical USA and Colombia ("Blue Zone") children.
View Article and Find Full Text PDFArticle Synopsis
- - Cervical cancer is the third most common female cancer globally and while chemoradiotherapy can improve survival by 6%, it often leads to serious side effects that diminish quality of life due to bone marrow suppression from pelvic radiation.
- - A study of 69 patients with advanced cervical cancer analyzed their blood cell counts and side effects during treatment, revealing that factors like BMI, age, and radiation dose were linked to significant drops in hemoglobin and other blood cell levels.
- - Specific radiation doses and techniques were found to correlate with severe blood count reductions, with neutropenia linked to gastrointestinal issues and a notable drop in leukocyte levels occurring around day 35 of treatment with 3D conformal radiotherapy.
: Small-cell lung cancer (SCLC) is an aggressive form of cancer with a poor prognosis. The two-year survival rate is 8% of all cases. : We present the case of a male patient who was 50 years old at the time of diagnosis in May 2022.
View Article and Find Full Text PDFIntroduction: Patients with non-small cell lung cancer (NSCLC) and brain metastatic disease have an unfavorable prognosis. The goal of the treatment in stage IV NSCLC is to increase the survival rate and to improve the quality of life.
Case Report: We present the case of a young male patient (47 years old at the time of diagnosis in 2021) with NSCLC stage IV with the onset of the disease through neurological symptoms determined by brain metastasis.